Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2016-10-22
Target enrollment:
Participant gender:
Summary
The objective of the study is to observe the effect of adherence to once-daily administered
long-acting bronchodilators (long-acting ß2-agonists [LABAs] / long-acting muscarinic
antagonists [LAMAs]) on patients health related quality of life (HR-QoL) and to assess the
relation between symptoms improvement and adherence to Chronic Obstructive Pulmonary Disease
(COPD) maintenance therapy